Rise Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-500
| Closed | -$4.16K | – | 1124 |
|
|
2024
Q3 | $4.16K | Hold |
500
| – | – | ﹤0.01% | 1091 |
|
|
2024
Q2 | $3.18K | Hold |
500
| – | – | ﹤0.01% | 1097 |
|
|
2024
Q1 | $3.03K | Hold |
500
| – | – | ﹤0.01% | 1116 |
|
|
2023
Q4 | $3.04K | Hold |
500
| – | – | ﹤0.01% | 426 |
|
|
2023
Q3 | $2.11K | Hold |
500
| – | – | ﹤0.01% | 460 |
|
|
2023
Q2 | $1.55K | Hold |
500
| – | – | ﹤0.01% | 543 |
|
|
2023
Q1 | $695 | Hold |
500
| – | – | ﹤0.01% | 702 |
|
|
2022
Q4 | $995 | Hold |
500
| – | – | ﹤0.01% | 650 |
|
|
2022
Q3 | $1K | Hold |
500
| – | – | ﹤0.01% | 593 |
|
|
2022
Q2 | $2K | Hold |
500
| – | – | ﹤0.01% | 533 |
|
|
2022
Q1 | $2K | Hold |
500
| – | – | ﹤0.01% | 515 |
|
|
2021
Q4 | $2.4K | Buy |
+500
| New | +$2.4K | ﹤0.01% | 508 |
|